跳至主要内容
临床试验/NCT05829902
NCT05829902已完成不适用

Evaluation of an Herbal Extract on Sleep Parameters in Healthy, Middle-aged Women

Aventure AB1 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2023年9月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Aventure AB
入组人数
52
试验地点
1
主要终点
Sleep onset latency

研究概览

简要总结

The overall purpose of this interventional study is to investigate how a specific herbal extract influences the quality of sleep in middle-aged women with mild to moderate insomnia. During the study, the participants are asked to take the test drink every night for two weeks. Both objective (Oura ring) and subjective (analog sleep diaries, questionnaires) measures are included to evaluate sleep parameters as well as perceived alertness and impact on daily functions. The primary outcome is sleep onset latency (SOL), which is the time it takes for a person to fall asleep. Secondary outcomes which will be evaluated include time spent in different sleep stages, number of times waking up during the night, and various qualitative ratings of energy levels and mood during the day.

Researchers will compare the group with active product and placebo product to see if the consumption of the herbal extract will lead to improvements in the factors mentioned above.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

A copy of the randomization list will be provided to those packing the product kits. The randomization list is a document that consists of randomization numbers, which uniquely assign each study patient to one of the treatments. The sponsor and all staff directly involved in the trial will thus be blinded to the product allocated to the participants. The randomization number will be documented.

入排标准

年龄范围
35 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者
是

入选标准

  • •Age 35-60
  • •BMI 18-30 kg/m2
  • •Mild to moderate insomnia according to the ISI (Insomnia Severity Index) questionnaire (ISI-value 10-21)
  • •Matching results from the Oura ring and sleep diaries during the run-in period

排除标准

  • •Metabolic disease (diabetes, cardiovascular disorders, hypo- or hyperthyroidism, etc)
  • •Severe psychiatric disorders
  • •Pregnancy, breastfeeding
  • •Restless legs or leg cramps that influence sleep and everyday life
  • •Conditions that prevent sleep through the symptoms that they produce (pain, nightly coughs, etc)
  • •Breathing problems (asthma, severe snoring, sleep apnea, etc)
  • •Medication that can influence sleep and/or wakefulness
  • •Consumption of herbal sedatives during the last month
  • •Having someone in the household that needs to be tended to during the night and pose a major risk to disturb the research participant's sleep to a large extent.
  • •Irregular work hours, including shift work at night
  • •Regularly sleeping more than 1 night per week away from home
  • •Tobacco or drug use
  • •Other factors that are deemed to influence participation negatively

研究组 & 干预措施

Active product

Experimental

The active product is a drink consisting of 600 mg of lemon balm extract, tea leaves, brown sugar and powdered flavoring agent that is mixed with lukewarm water. The volume per serving is 30 ml. The drink will be taken every night before sleep for a period of two weeks.

干预措施: Herbal extract drink (Other)

Placebo

Placebo Comparator

The placebo drink is maltodextrin mixed with water, and the same tea leaves, brown sugar and powdered flavoring agent as the test drink. The volume per serving is 30 ml. The drink will be taken every night before sleep for a period of two weeks.

干预措施: Placebo (Other)

结局指标

主要结局

Sleep onset latency

时间窗: 2 weeks

The length of time it takes a person to fall asleep when turning the lights off, this parameter will be measured by using the Oura Ring

次要结局

  • Perceived alertness and wellbeing during the day(2 weeks)
  • Time spent in different sleep stages(2 weeks)

研究者

发起方
Aventure AB
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验